The Filing Desk

Century Therapeutics vs Sutro Biopharma

Century Therapeutics IPSC · Sutro Biopharma STRO · Biotechnology

Century Therapeutics reported revenue of $109 million in fiscal 2025, about the same as Sutro Biopharma's $102 million in fiscal 2025. Century Therapeutics' revenue grew 1556.8% in its latest year, and Sutro Biopharma's grew 65.2%. Century Therapeutics had an operating margin of -15.8%, against -154.5% at Sutro Biopharma.

Side by side

Century TherapeuticsSutro Biopharma
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$109M$102M
Revenue growth1,556.8%65.2%
Revenue growth a year, last 5 years—19.1%
Gross margin——
Operating margin−15.8%−154.5%
Net margin−8.8%−186.4%
Free cash flow−$105M—
Free cash flow margin−95.9%—
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count10.1%9.8%
Last close$1.32$8.72
P/E at the last close——
Insider trades, last 12 monthsbought $79,511, sold $71,284—
Piotroski F-score—2 of 8
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Century TherapeuticsSutro Biopharma
Operating margin
Percent of revenue
Century TherapeuticsSutro Biopharma
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Century TherapeuticsSutro Biopharma

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Century Therapeutics and Sutro Biopharma pages.